as on December 16, 2025 at 2:29 am IST
Day's Low
Day's High
0.84%
Downside
2.14%
Upside
52 Week's Low
52 Week's High
63.32%
Downside
16.85%
Upside
Check Centessa Pharmaceuticals-adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.9B
EPS (TTM)
-1.343
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-213.5M
Revenue (TTM)
15.0M
Profit Margin
0.00%
Return On Equity TTM
-60.62%
Compare market cap, revenue, PE, and other key metrics of Centessa Pharmaceuticals-adr with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.9B | NA | NA | 0.00% | |
| BUY | $42.0B | 439.95% | -16.34 | -264.83% | |
| BUY | $52.5B | 183.04% | 1242.34 | 1.36% | |
| BUY | $115.9B | 96.33% | 31.86 | 31.35% | |
| BUY | $78.6B | 54.68% | 17.76 | 32.13% |
The Centessa Pharmaceuticals-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Centessa Pharmaceuticals-adr investment value today
Current value as on today
₹1,63,028
Returns
₹63,028
(+63.03%)
Returns from Centessa Pharmaceuticals-adr Stock
₹56,239 (+56.24%)
Dollar Returns*
₹6,790 (+6.79%)
Based on 11 analysts
81.82%
Buy
18.18%
Hold
0.00%
Sell
Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Centessa Pharmaceuticals-adr. Average target price of $37.67
Get share price movements and forecasts by analysts on Centessa Pharmaceuticals-adr.
What analysts predicted
30.53%UPSIDE
Target Price
$37.67
Current Price
$26.17
Analyzed by
11 Analysts
Target
$37.67
Centessa Pharmaceuticals-adr target price $37.67, a slight upside of 30.53% compared to current price of $26.17. According to 11 analysts rating.
Search interest for Centessa Pharmaceuticals-adr Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 11 November
Wed, 02:30 AM
-Centessa Pharmaceuticals announces an underwritten public offering of American Depositary Shares, with a potential 30-day option for underwriters.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 6 months, CNTA stock has moved up by 110.4%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 168.4% return, outperforming this stock by 110.1%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 931.5% return, outperforming this stock by 218.3%
| Organisation | Centessa Pharmaceuticals-adr |
| Headquarters | 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT |
| Industry | Healthcare |
| CEO | Dr. Saurabh Saha M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Kristen K. Sheppard Esq., J.D. | Senior Vice President of Investor Relations & Corporate Communications |
Ms. Karen M. Anderson | Chief People Officer |
Dr. Mario Alberto Accardi Ph.D. | President of the Orexin Program |
Dr. Saurabh Saha M.D., Ph.D. | CEO & Director |
Mr. John J. Crowley CPA | CFO & Principal Financial Officer |
Mr. Raphael Deferiere CPA | Chief Accounting Officer & Principal Accounting Officer |
Ms. Charlene Stoudt | Senior Vice President of Clinical Development Operations |
Mr. Iqbal J. Hussain L.L.B. | General Counsel, Chief Compliance Officer & Corporate Secretary |
Ms. Tia L. Bush | Chief Technology & Quality Officer |
Dr. Gregory M. Weinhoff M.B.A., M.D. | Chief Business Officer |
Centessa Pharmaceuticals-adr share price today is $26.17 as on at the close of the market. Centessa Pharmaceuticals-adr share today touched a day high of $26.73 and a low of $25.95.
Centessa Pharmaceuticals-adr share touched a 52 week high of $30.58 on and a 52 week low of $9.6 on . Centessa Pharmaceuticals-adr stock price today i.e. is closed at $26.17,which is 14.42% down from its 52 week high and 172.60% up from its 52 week low.
Centessa Pharmaceuticals-adr market capitalisation is $0.00T as on .
Indian investors can start investing in Centessa Pharmaceuticals-adr (CNTA) shares with as little as ₹90.683 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.83 in Centessa Pharmaceuticals-adr stock (as per the Rupee-Dollar exchange rate as on ).
Based on Centessa Pharmaceuticals-adr share’s latest price of $26.17 as on December 16, 2025 at 2:29 am IST, you will get 0.3821 shares of Centessa Pharmaceuticals-adr. Learn more about
fractional shares .